CTTH — CTT PHARMACEUTICAL HOLDINGS, INC.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1035422 ·
Last close
$0.07
Market Cap
$3.87M
52W High
$0.08
52W Low
$0.06
ADV30
24,199
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -84,674 | -84,674 | 76,195 | 7,089 | 34,918 |
| Dec 2025 | 0 | — | -48,251 | -50,255 | 86,168 | 15,359 | 31,018 |
| Sep 2025 | 0 | — | -15,379 | -15,379 | 102,803 | 30,544 | 21,043 |
| Jun 2025 | 0 | — | -60,771 | -60,729 | 102,168 | 32,439 | 20,029 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-50,675
Investing CF
—
Financing CF
$90,800
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-05-25
Balance + Analyst (yfinance extras)
Retained Earnings
$-7,636,137
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-114,218
Pretax Income TTM
$-114,218
Interest Exp TTM
$0
Analysts
—
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -153,903 | -155,907 | 86,168 | 31,018 | — | -75,467 |
| Dec 2024 | 0 | -250,229 | -250,229 | 73,042 | 40,859 | — | -228,320 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ENSC | Ensysce Biosciences, Inc. | $3.89M | $0.25 | — |
| MBIO | MUSTANG BIO, INC. | $3.84M | $0.57 | — |
| ERNA | Ernexa Therapeutics Inc. | $3.83M | $3.28 | — |
| RDHL | RedHill Biopharma Ltd. | $3.95M | $0.65 | — |
| REVB | REVELATION BIOSCIENCES, INC. | $3.71M | $0.95 | — |
News headlines (Yahoo Finance, 1h cache)
CTT Pharma Signs LOI for Clinical Trials and Testing of Nicotine Products
2026-06-22 10:00 · Yahoo
CTT Pharma Signs LOI with European Company
2026-06-17 10:00 · Yahoo
CTT Pharmaceutical Holdings, Inc. Files Form S-1 Registration Statement and Advances Equity Line of Credit and Scientific Development Milestones
2025-12-30 11:00 · Yahoo
CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics
2025-12-16 11:00 · Yahoo
CTT Pharma CEO Issues Letter to Shareholders
2025-12-02 12:00 · Yahoo
CTT Pharma's CEO Will Issue a Letter to Shareholders
2025-11-20 14:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.